713 related articles for article (PubMed ID: 24290832)
21. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
22. A Decade of Experience With Continuous-Flow Left Ventricular Assist Devices.
John R; Holley CT; Eckman P; Roy SS; Cogswell R; Harvey L; Shumway S; Liao K
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):363-375. PubMed ID: 28043445
[TBL] [Abstract][Full Text] [Related]
23. Design changes in continuous-flow left ventricular assist devices and life-threatening pump malfunctions.
Soltani S; Kaufmann F; Vierecke J; Kretzschmar A; Hennig E; Stein J; Hetzer R; Krabatsch T; Potapov EV
Eur J Cardiothorac Surg; 2015 Jun; 47(6):984-9. PubMed ID: 25209626
[TBL] [Abstract][Full Text] [Related]
24. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
[TBL] [Abstract][Full Text] [Related]
25. Activated partial thromboplastin time overestimates anti-coagulation in left ventricular assist device patients.
McIlvennan CK; Page RL; Ambardekar AV; Brieke A; Lindenfeld J
J Heart Lung Transplant; 2014 Dec; 33(12):1312-4. PubMed ID: 25443872
[No Abstract] [Full Text] [Related]
26. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
[TBL] [Abstract][Full Text] [Related]
27. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients.
Boyle AJ; Jorde UP; Sun B; Park SJ; Milano CA; Frazier OH; Sundareswaran KS; Farrar DJ; Russell SD;
J Am Coll Cardiol; 2014 Mar; 63(9):880-8. PubMed ID: 24316083
[TBL] [Abstract][Full Text] [Related]
28. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
[TBL] [Abstract][Full Text] [Related]
29. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
[TBL] [Abstract][Full Text] [Related]
30. Antiplatelet Therapy and Adverse Hematologic Events During Heart Mate II Support.
Saeed O; Shah A; Kargoli F; Madan S; Levin AP; Patel SR; Jermyn R; Guerrero C; Nguyen J; Sims DB; Shin J; D'Alessandro D; Goldstein DJ; Jorde UP
Circ Heart Fail; 2016 Jan; 9(1):e002296. PubMed ID: 26721914
[TBL] [Abstract][Full Text] [Related]
31. Device thrombosis in continuous-flow left ventricular assist devices: a new manifestation of Kounis syndrome?
Kounis NG; Soufras GD; Davlouros P
J Heart Lung Transplant; 2014 Jun; 33(6):665. PubMed ID: 24726423
[No Abstract] [Full Text] [Related]
32. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
[TBL] [Abstract][Full Text] [Related]
33. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
[TBL] [Abstract][Full Text] [Related]
34. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
35. Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events.
Salerno CT; Sundareswaran KS; Schleeter TP; Moanie SL; Farrar DJ; Walsh MN
J Heart Lung Transplant; 2014 Aug; 33(8):809-15. PubMed ID: 24735680
[TBL] [Abstract][Full Text] [Related]
36. Thrombosis in Continuous Flow Left Ventricular Assist Devices: Our Clinical Experience With Medical and Surgical Management.
Köksel U; Erbasan O; Bayezid Ö; Kemaloğlu C; Özçobanoğlu S; Gölbaşı I; Türkay C
Transplant Proc; 2016; 48(6):2162-7. PubMed ID: 27569964
[TBL] [Abstract][Full Text] [Related]
37. Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients.
Lopilato AC; Doligalski CT; Caldeira C
Artif Organs; 2015 Nov; 39(11):939-44. PubMed ID: 25912789
[TBL] [Abstract][Full Text] [Related]
38. In vitro hemodynamic characterization of HeartMate II at 6000 rpm: Implications for weaning and recovery.
Sunagawa G; Byram N; Karimov JH; Horvath DJ; Moazami N; Starling RC; Fukamachi K
J Thorac Cardiovasc Surg; 2015 Aug; 150(2):343-8. PubMed ID: 26204865
[TBL] [Abstract][Full Text] [Related]
39. Aortic valve opening and thrombotic events with continuous-flow left ventricular assist devices.
Saeed O; Maybaum S; Alessandro DD; Goldstein DJ; Patel SR
J Heart Lung Transplant; 2014 Jan; 33(1):109-12. PubMed ID: 23937883
[No Abstract] [Full Text] [Related]
40. Continuous-flow left ventricular assist device exchange: clinical outcomes.
Ota T; Yerebakan H; Akashi H; Takayama H; Uriel N; Colombo PC; Jorde UP; Naka Y
J Heart Lung Transplant; 2014 Jan; 33(1):65-70. PubMed ID: 23937885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
